Jennison Associates LLC Purchases New Position in Encompass Health Co. (NYSE:EHC)

Jennison Associates LLC acquired a new stake in Encompass Health Co. (NYSE:EHC) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 564,097 shares of the company’s stock, valued at approximately $52,094,000. Jennison Associates LLC owned approximately 0.56% of Encompass Health at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. CIBC Asset Management Inc grew its holdings in shares of Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares in the last quarter. Miracle Mile Advisors LLC lifted its position in Encompass Health by 3.0% during the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after purchasing an additional 112 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares during the last quarter. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Finally, Verdence Capital Advisors LLC lifted its holdings in shares of Encompass Health by 4.6% during the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after acquiring an additional 160 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 0.7 %

NYSE:EHC opened at $101.28 on Wednesday. The firm has a market capitalization of $10.20 billion, a P/E ratio of 24.46, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health Co. has a 52 week low of $70.83 and a 52 week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a fifty day moving average of $96.44 and a 200 day moving average of $95.03.

Wall Street Analyst Weigh In

A number of research analysts recently commented on EHC shares. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays upped their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.